Brian G. Drazba
2015 - Heron Therapeutics
In 2015, Brian G. Drazba earned a total compensation of $1.5M as Vice President, Finance and Chief Financial Officer at Heron Therapeutics, a 152% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $97,855 |
|---|---|
| Option Awards | $1,116,535 |
| Salary | $310,650 |
| Other | $7,950 |
| Total | $1,532,990 |
Drazba received $1.1M in option awards, accounting for 73% of the total pay in 2015.
Drazba also received $97.9K in non-equity incentive plan, $310.7K in salary and $8K in other compensation.
Rankings
In 2015, Brian G. Drazba's compensation ranked 5,875th out of 13,638 executives tracked by ExecPay. In other words, Drazba earned more than 56.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,875 out of 13,638 | 57th |
Division Manufacturing | 2,188 out of 5,190 | 58th |
Major group Chemicals And Allied Products | 790 out of 1,854 | 57th |
Industry group Drugs | 630 out of 1,528 | 59th |
Industry Pharmaceutical Preparations | 494 out of 1,182 | 58th |
Source: SEC filing on April 29, 2016.
Drazba's colleagues
We found four more compensation records of executives who worked with Brian G. Drazba at Heron Therapeutics in 2015.